DaVita (LTS:0I7E) Cash Flow from Others : $69 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is DaVita Cash Flow from Others?

DaVita's cash flow from others for the three months ended in Mar. 2025 was $27 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2025 was $69 Mil.

DaVita Cash Flow from Others Historical Data

The historical data trend for DaVita's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cash Flow from Others Chart

DaVita Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

125.78

16.45

30.47

62.97

32.31

DaVita Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow from Others	Get a 7-Day Free Trial															-8.98	47.59	54.02	-60.33	27.40

DaVita Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $69 Mil.

DaVita Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of DaVita's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (LTS:0I7E) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany DVAI34:Brazil

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

DaVita Headlines

No Headlines